Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain. Sanchez-de la Rosa R, Sabater E, Casado MA Health Econ Rev. 2013 May 7; 3(1):13. Epub 2013 May 07. PMID: 23647721. Abstract CommentRecommendBookmarkWatch